[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100627515":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":11,"locations":17,"responsibleParty":32,"collaborators":36,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":10,"eligibilityCriteria":45,"healthyVolunteers":41,"sex":46,"minAge":47,"maxAge":10,"enrollmentInfo":48,"targetDuration":10,"studyType":51,"phases":10,"briefSummary":52,"conditions":53,"keywords":55,"overallStatus":57,"whyStopped":10,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"Sohag University","OTHER",[8],{"label":9,"type":10,"description":10,"interventionNames":10},"Patients with intermediate-stage hepatocellular carcinoma (BCLC-B)",null,[12],{"name":13,"role":14,"phone":15,"phoneExt":10,"email":16},"Mohammed Hamdy","CONTACT","+201101501551","mohammedzohry2018@gmail.com",[18],{"facility":19,"status":10,"city":20,"state":21,"zip":10,"country":22,"countryCode":23,"cosmosGeoPoint":24,"geoPoint":29,"contacts":30},"Sohag Oncology Center","Sohag","Sohag Governorate","Egypt","EG",{"type":25,"coordinates":26},"Point",[27,28],31.69478,26.55695,{"lat":28,"lon":27},[31],{"name":13,"role":14,"phone":15,"phoneExt":10,"email":16},{"type":33,"investigatorFullName":34,"investigatorTitle":35,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Mohammed Hamdy Zohry","Resident in Internal Medicine Department, Faculty of Medicine, Sohag University",[37],{"name":19,"class":38},"OTHER_GOV","100627515","real-world-treatment-patterns-and-survival-outcomes-in-patients-with-intermediate-stage-hepatocellular-carcinoma-100627515",false,"NCT07449637","Real-World Treatment Patterns and Survival Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma.","Real-World Treatment Patterns and Survival Outcomes in Patients With Intermediate-Stage Hepatocellular Carcinoma: An Observational Cohort Study.","Inclusion Criteria:\n\n* Aged ≥18 years.\n* Both sexes.\n* Diagnosis of hepatocellular carcinoma based on accepted radiologic or histologic criteria.\n* Classified as intermediate stage (BCLC-B) at time of decision for first-line treatment.\n* Child-Pugh A or B.\n* ECOG performance status 0-1.\n\nExclusion Criteria:\n\n* BCLC A, C, or D at diagnosis.\n* Prior curative therapy (resection, transplantation, curative ablation).\n* Missing essential data (imaging, liver function, treatment records).\n* Mixed HCC-cholangiocarcinoma.","ALL","18 Years",{"count":49,"type":50},200,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to learn about the different treatment options for intermediate-stage hepatocellular carcinoma. The main question it aims to answer is:\n\n\\- What are the survival outcomes among participants aged 18 or older who receive treatment for intermediate-stage hepatocellular carcinoma?",[54],"BCLC Stage B Hepatocellular Carcinoma",[56],"Intermediate-Stage Hepatocellular Carcinoma","NOT_YET_RECRUITING","2026-02-27",{"date":60,"type":61},"2026-03-04","ACTUAL",{"date":63,"type":50},"2026-03",{"date":65,"type":50},"2026-07",{"name":5,"class":6},1]